YGEIA Group

YGEIA Group is revolutionizing clinical care with its focus on personalized medicine for chronic disease management at home. In an era of digital transformation, patient empowerment and personalized engagement are becoming increasingly essential. YGEIA addresses these needs with a best-in-class solution that leverages technology to provide actionable data at the patient level. This allows for the creation of personalized treatment plans, leading to reduced hospital readmissions, increased patient engagement, and improved outcomes. Founded in 2014 and based in the United States, the company received a $50.00K Seed Round investment in July 2014. With its emphasis on bringing precision medicine to the forefront of chronic disease management, YGEIA presents a promising opportunity for investors in the Health Care and Information Technology industries.